Search

everythinglearnresearchcommunity

for

Search:↓

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

The new minoxidil hydrogel improves delivery and is safe for treating hair loss.

Exosomes could improve skin care, but more research is needed to confirm their safety and effectiveness.

The new hydrogel treatment promotes faster hair growth and better skin health for hair loss.

Hair follicle and adipose cell vesicles both protect neurons and reduce inflammation similarly.

Different substances can affect how well the skin absorbs minoxidil, a hair loss drug. Caprylic acid helps the skin absorb it the best, followed by propylene glycol and water.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

Liposome-based cosmeceuticals improve treatment effectiveness for skin and hair conditions.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

Nanoemulgel is a better way to deliver drugs through the skin for various conditions.

Adapalene microemulsions improve drug delivery through hair follicles, enhancing acne treatment.

Exosome therapy could revolutionize stroke treatment, but more research is needed for human use.

Polyamidoamine dendrimers can change the strength and direction of electroosmotic flow through the skin, affecting drug delivery.

Milk-derived exosomes may help treat hair loss by boosting hair follicle growth.

Liposomes improve minoxidil delivery to hair follicles, enhancing treatment for hair loss.

High-temperature gelatinization of ginkgo seeds effectively increases β-cyclodextrin production.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Natural hydrogels can improve wound healing but face challenges in becoming widely used in clinics.

VEGF promotes hair follicle cell growth through the VEGFR-2/ERK pathway.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Nanoformulations improve drug delivery through the skin, reducing side effects and enhancing effectiveness.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

Nano-phytopharmaceuticals show promise but need more research for safe, effective use in treating certain disorders.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.